30Oct
[Video] I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues - Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
AGG is pleased to present the second episode in a podcast series titled, “I Wish I Know What I Know Now: Conversations with AGG on FDA Issues,” covering key due diligence issues to consider when acquiring or investing in life science companies or products. In this episode, AGG partner Alan G. Minsk and Brian A. Teras provides an overview of the diligence process, potential red flags, common mistakes, and other factors to consider during the due diligence process. Each month, we'll release a...
By:
Arnall Golden Gregory LLP
Related
At the end of 2019, Dutch department store chain HEMA announced it was going to stop using fingerpri...
Read More >
On a matter of first impression, the Delaware Court of Chancery (the Court) found in In re WeWork Li...
Read More >
Dear Sir/Madam, We would like to alert you to the new rules for entering the Russian Federation thr...
Read More >
The U.S. Court of Appeals for the Tenth Circuit was not persuaded that because marijuana remains ill...
Read More >
I have life insurance and it’s an important financial tool to protect your loved ones. I’ve never ...
Read More >
I’ve been to a lot of baby showers lately where it seems like the parents-to-be are showered with a...
Read More >